Gene · 7150
Papers4,103
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
561 to 580 of 4,103
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| An integrative mathematical model for timing treatment toxicity and Zeitgeber impact in colorectal cancer cells. | NPJ Syst Biol Appl | 2023 | 37353516 | PubTator, text mining | PubMed |
| Targeting neddylation sensitizes colorectal cancer to topoisomerase I inhibitors by inactivating the DCAF13-CRL4 ubiquitin ligase complex. | Nat Commun | 2023 | 37353483 | PubTator, text mining | PubMed |
| MTX-13, a Novel PTK7-Directed Antibody-Drug Conjugate with Widened Therapeutic Index Shows Sustained Tumor Regressions for a Broader Spectrum of PTK7-Positive Tumors. | Mol Cancer Ther | 2023 | 37352387 | PubTator, text mining | PubMed |
| Time-dependent recruitment of GAF, ISGF3 and IRF1 complexes shapes IFNα and IFNγ-activated transcriptional responses and explains mechanistic and functional overlap. | Cell Mol Life Sci | 2023 | 37347298 | PubTator, text mining | PubMed |
| Image classification model based on large kernel attention mechanism and relative position self-attention mechanism. | PeerJ Comput Sci | 2023 | 37346614 | PubTator, text mining | PubMed |
| Pharmacological modulators of epithelial immunity uncovered by synthetic genetic tracing of SARS-CoV-2 infection responses. | Sci Adv | 2023 | 37343108 | PubTator, text mining | PubMed |
| Diphenyl ditelluride anticancer activity and DNA topoisomerase I poisoning in human colon cancer HCT116 cells. | Oncotarget | 2023 | 37343056 | PubTator, text mining | PubMed |
| Proteogenomic landscape of gastric adenocarcinoma peritoneal metastases. | iScience | 2023 | 37305699 | PubTator, text mining | PubMed |
| AMT-562, a Novel HER3-targeting Antibody-Drug Conjugate, Demonstrates a Potential to Broaden Therapeutic Opportunities for HER3-expressing Tumors. | Mol Cancer Ther | 2023 | 37302522 | PubTator, text mining | PubMed |
| New 5-Hydroxycoumarin-Based Tyrosyl-DNA Phosphodiesterase I Inhibitors Sensitize Tumor Cell Line to Topotecan. | Int J Mol Sci | 2023 | 37298106 | PubTator, text mining | PubMed |
| New Biomarkers and Treatment Advances in Triple-Negative Breast Cancer. | Diagnostics (Basel) | 2023 | 37296801 | PubTator, text mining | PubMed |
| Experimental systems for the analysis of mutational signatures: no 'one-size-fits-all' solution. | Biochem Soc Trans | 2023 | 37283472 | PubTator, text mining | PubMed |
| NPM3 as a novel oncogenic factor and poor prognostic marker contributes to cell proliferation and migration in lung adenocarcinoma. | Hereditas | 2023 | 37254219 | PubTator, text mining | PubMed |
| DNA topoisomerase 1 represses HIV-1 promoter activity through its interaction with a guanine quadruplex present in the LTR sequence. | Retrovirology | 2023 | 37254203 | PubTator, text mining | PubMed |
| Isoliquiritigenin inhibits circ0030018 to suppress glioma tumorigenesis via the miR-1236/HER2 signaling pathway. | MedComm (2020) | 2023 | 37250146 | PubTator, text mining | PubMed |
| Gel-Free Tools for Quick and Simple Screening of Anti-Topoisomerase 1 Compounds. | Pharmaceuticals (Basel) | 2023 | 37242440 | PubTator, text mining | PubMed |
| Preliminary In Vitro and In Vivo Insights of In Silico Candidate Repurposed Drugs for Alzheimer's Disease. | Life (Basel) | 2023 | 37240740 | PubTator, text mining | PubMed |
| Targeted Therapies in Small Cell Lung Cancer: From Old Failures to Novel Therapeutic Strategies. | Int J Mol Sci | 2023 | 37240229 | PubTator, text mining | PubMed |
| Evolution of Resistance to Irinotecan in Cancer Cells Involves Generation of Topoisomerase-Guided Mutations in Non-Coding Genome That Reduce the Chances of DNA Breaks. | Int J Mol Sci | 2023 | 37240063 | PubTator, text mining | PubMed |
| GPR19 Coordinates Multiple Molecular Aspects of Stress Responses Associated with the Aging Process. | Int J Mol Sci | 2023 | 37239845 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7150/papers?page=29